Cargando…
Development of a Human iPSC Cardiomyocyte-Based Scoring System for Cardiac Hazard Identification in Early Drug Safety De-risking
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have emerged as a promising cardiac safety platform, demonstrated by numerous validation studies using drugs with known cardiac adverse effects in humans. However, the challenge remains to implement hiPSC-CMs into cardiac de-risk...
Autores principales: | Kopljar, Ivan, Lu, Hua Rong, Van Ammel, Karel, Otava, Martin, Tekle, Fetene, Teisman, Ard, Gallacher, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294263/ https://www.ncbi.nlm.nih.gov/pubmed/30540961 http://dx.doi.org/10.1016/j.stemcr.2018.11.007 |
Ejemplares similares
-
Identifying Acute Cardiac Hazard in Early Drug Discovery Using a Calcium Transient High-Throughput Assay in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lu, Hua Rong, et al.
Publicado: (2022) -
High-Throughput Screening Assay for Detecting Drug-Induced Changes in Synchronized Neuronal Oscillations and Potential Seizure Risk Based on Ca(2+) Fluorescence Measurements in Human Induced Pluripotent Stem Cell (hiPSC)-Derived Neuronal 2D and 3D Cultures
por: Lu, Hua-Rong, et al.
Publicado: (2023) -
Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
por: Altrocchi, C., et al.
Publicado: (2023) -
Pharmacological Profile of the Sodium Current in Human Stem Cell-Derived Cardiomyocytes Compares to Heterologous Nav1.5+β1 Model
por: Van de Sande, Dieter V., et al.
Publicado: (2019) -
Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)